Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial
Open Access
- 29 October 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Respiratory Research
- Vol. 14 (1), 116
- https://doi.org/10.1186/1465-9921-14-116
Abstract
Data examining the characteristics of patients with frequent exacerbations of chronic obstructive pulmonary disease (COPD) and associated hospitalisations and mortality are scarce. Post-hoc analysis of the Prevention Of Exacerbations with Tiotropium in COPD (POET-COPD) trial, targeting exacerbations as the primary endpoint. Patients were classified as non-, infrequent, and frequent exacerbators (0, 1, or ≥ 2 exacerbations during study treatment), irrespective of study treatment. A multivariate Cox regression model assessed the effect of covariates on time to first exacerbation. In total, 7376 patients were included in the analysis: 63.5% non-exacerbators, 22.9% infrequent, 13.6% frequent exacerbators. Factors significantly associated with exacerbation risk were age, sex, body mass index, COPD duration and severity, smoking history, baseline inhaled corticosteroid use, and preceding antibiotic or systemic corticosteroid courses. Frequent exacerbators had greater severity and duration of COPD, received more pulmonary medication, and ≥ 2 systemic corticosteroid or antibiotic courses in the preceding year, and were more likely to be female and ex-smokers. The small proportion of frequent exacerbators (13.6%) accounted for 56.6% of exacerbation-related hospitalisations, which, overall, were associated with a three-fold increase in mortality. The frequent exacerbator phenotype was closely associated with exacerbation-related hospitalisations, and exacerbation-related hospitalisations were associated with poorer survival. NCT00563381; Study identifier: BI 205.389.Keywords
This publication has 24 references indexed in Scilit:
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortalityThorax, 2012
- The clinical features of the overlap between COPD and asthmaRespiratory Research, 2011
- Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH studyEuropean Respiratory Journal, 2011
- Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPDThe New England Journal of Medicine, 2011
- Susceptibility to Exacerbation in Chronic Obstructive Pulmonary DiseaseThe New England Journal of Medicine, 2010
- Clinical COPD phenotypes: a novel approach using principal component and cluster analysesEuropean Respiratory Journal, 2010
- A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary DiseaseThe New England Journal of Medicine, 2008
- What have we learned from large drug treatment trials in COPD?The Lancet, 2007
- International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence studyThe Lancet, 2007